154 related articles for article (PubMed ID: 7718333)
1. Multi-modality megatherapy with [131I]meta-iodobenzylguanidine, high dose melphalan and total body irradiation with bone marrow rescue: feasibility study of a new strategy for advanced neuroblastoma.
Gaze MN; Wheldon TE; O'Donoghue JA; Hilditch TE; McNee SG; Simpson E; Barrett A
Eur J Cancer; 1995; 31A(2):252-6. PubMed ID: 7718333
[TBL] [Abstract][Full Text] [Related]
2. [131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma.
Corbett R; Pinkerton R; Tait D; Meller S
J Nucl Biol Med (1991); 1991; 35(4):228-31. PubMed ID: 1823824
[TBL] [Abstract][Full Text] [Related]
3. 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Nucl Med Commun; 1994 Sep; 15(9):712-7. PubMed ID: 7816384
[TBL] [Abstract][Full Text] [Related]
4. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
Mastrangelo R; Tornesello A; Riccardi R; Lasorella A; Mastrangelo S; Mancini A; Rufini V; Troncone L
Eur J Cancer; 1995; 31A(4):606-11. PubMed ID: 7576979
[TBL] [Abstract][Full Text] [Related]
5. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients.
Klingebiel T; Feine U; Treuner J; Reuland P; Handgretinger R; Niethammer D
J Nucl Biol Med (1991); 1991; 35(4):216-9. PubMed ID: 1823821
[TBL] [Abstract][Full Text] [Related]
6. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
7. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
[TBL] [Abstract][Full Text] [Related]
8. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
[TBL] [Abstract][Full Text] [Related]
10.
Giardino S; Piccardo A; Conte M; Puntoni M; Bertelli E; Sorrentino S; Montera M; Risso M; Caviglia I; Altrinetti V; Lanino E; Faraci M; Garaventa A
Pediatr Blood Cancer; 2021 Feb; 68(2):e28775. PubMed ID: 33099289
[TBL] [Abstract][Full Text] [Related]
11. High-dose melphalan with 6-hydroxydopamine-purged autologous bone marrow transplantation for poor-risk neuroblastoma.
Kushner BH; Gulati SC; Kwon JH; O'Reilly RJ; Exelby PR; Cheung NK
Cancer; 1991 Jul; 68(2):242-7. PubMed ID: 1906368
[TBL] [Abstract][Full Text] [Related]
12. Double megatherapy and autologous bone marrow transplantation for advanced neuroblastoma: the LMCE2 study.
Philip T; Ladenstein R; Zucker JM; Pinkerton R; Bouffet E; Louis D; Siegert W; Bernard JL; Frappaz D; Coze C
Br J Cancer; 1993 Jan; 67(1):119-27. PubMed ID: 8427772
[TBL] [Abstract][Full Text] [Related]
13. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
14. Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
Sisson JC; Hutchinson RJ; Carey JE; Shapiro B; Johnson JW; Mallette SA; Wieland DM
Eur J Nucl Med; 1988; 14(7-8):337-40. PubMed ID: 3181182
[TBL] [Abstract][Full Text] [Related]
15. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Miser JS; Zasadny KR; Normolle DP; Shulkin BL; Francis IR; Wieland DM; Shapiro B
J Nucl Biol Med (1991); 1991; 35(4):237-40. PubMed ID: 1823826
[TBL] [Abstract][Full Text] [Related]
17. Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Castellani MR; Rottoli L; Maffioli L; Massimino M; Gasparini M; Buraggi GL
J Nucl Biol Med (1991); 1991; 35(4):241-3. PubMed ID: 1726677
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators.
Lumbroso J; Hartmann O; Schlumberger M
J Nucl Biol Med (1991); 1991; 35(4):220-3. PubMed ID: 1823822
[TBL] [Abstract][Full Text] [Related]
19. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
[TBL] [Abstract][Full Text] [Related]
20. [Total body irradiation, vincristine in continuous infusion and high-dose melphalan with transplant of autologous bone marrow in the treatment of neuroblastoma].
Dini G; Garaventa A; Lanino E; Perin GP; Scarpati D; Viscoli C; Franchini E; Corvò R; Dallorso S; Cinollo G
Pediatr Med Chir; 1987; 9(1):1-7. PubMed ID: 3306621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]